UnitedHealthcare Provides Commercial Coverage for FoundationOne®CDx and FoundationOne®Liquid CDx in Multiple Companion Diagnostic Indications

FDA-approved FoundationOne®CDx will be the only tissue-based comprehensive genomic profiling test covered by UnitedHealthcare FDA-approved FoundationOne®Liquid CDxwill be covered for patients with advanced breast cancer, metastatic non-small cell lung cancer,...